Approval · Notice of Compliance 20892 · 2018
CAMBIA: Notice of Compliance 20892
Issued May 22, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20892
- Date
- May 22, 2018
- Company
- Aralez Pharmaceuticals Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAMBIA | 02381680 | Marketed |
Medicinal ingredients
- DICLOFENAC POTASSIUM 50 MG per PCK